These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21358725)

  • 1. Deal watch: Valuation benefits of structure-enabled drug discovery.
    Borshell N; Papp T; Congreve M
    Nat Rev Drug Discov; 2011 Mar; 10(3):166. PubMed ID: 21358725
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Innovative Medicine Initiative (IMI)].
    Bril A; Canet E
    Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global portfolio of new antimalarial medicines under development.
    Olliaro P; Wells TN
    Clin Pharmacol Ther; 2009 Jun; 85(6):584-95. PubMed ID: 19404247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pfizer's home remedy.
    Abkowitz A
    Fortune; 2009 Aug; 160(4):82-4, 86. PubMed ID: 19728588
    [No Abstract]   [Full Text] [Related]  

  • 6. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Medicines Company: an emerging pharmaceutical company in cardiology is spearheading an innovative approach to critical care medicines.
    Mayor S
    Eur Heart J; 2009 Jul; 30(13):1541-3. PubMed ID: 19579293
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 9. Driving operational excellence across research.
    Cunningham MR
    Drug Discov Today; 2011 Jul; 16(13-14):541-2. PubMed ID: 21558017
    [No Abstract]   [Full Text] [Related]  

  • 10. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 11. Increase in R&D openness to tackle disease in the developing world.
    Parks L
    Future Med Chem; 2012 Dec; 4(18):2237. PubMed ID: 23234547
    [No Abstract]   [Full Text] [Related]  

  • 12. The rise of micropharma.
    Barden CJ; Weaver DF
    Drug Discov Today; 2010 Feb; 15(3-4):84-7. PubMed ID: 19837185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RuiPing Dong. Interview by Asher Mullard.
    Dong R
    Nat Rev Drug Discov; 2012 Feb; 11(2):100. PubMed ID: 22293559
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategic groups in the biopharmaceutical industry: implications for performance.
    Erden Z; von Krogh G; Nytorp C; Hultberg M
    Drug Discov Today; 2009 Aug; 14(15-16):726-30. PubMed ID: 19416760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug discovery management, small is still beautiful: Why a number of companies get it wrong.
    Knutsen LJ
    Drug Discov Today; 2011 Jun; 16(11-12):476-84. PubMed ID: 21504798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deal watch: Trends in discovery externalization.
    Mayhew S
    Nat Rev Drug Discov; 2010 Mar; 9(3):183. PubMed ID: 20190781
    [No Abstract]   [Full Text] [Related]  

  • 17. An audience with Guido Rasi. Interview by Asher Mullard.
    Rasi G
    Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260
    [No Abstract]   [Full Text] [Related]  

  • 18. Deal watch: Abbott and Neurocrine to develop promising endometriosis drug.
    Nat Rev Drug Discov; 2010 Aug; 9(8):584. PubMed ID: 20671753
    [No Abstract]   [Full Text] [Related]  

  • 19. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future pharmaceutical research: the need to look beyond science.
    Seeger S
    Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.